[S-3] IGC Pharma, Inc. Shelf Registration Statement

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

S-3

Rhea-AI Filing Summary

Analyzing...

07/18/2025 - 05:17 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

IGC Pharma Inc

NYSE:IGC

IGC Rankings

#8515 Ranked by Market Cap

N/A Ranked by Dividends

#74 Top Loser

IGC Latest News

Jul 10, 2025

IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predict Alzheimer's Risk and Accelerate Early Detection

Jun 30, 2025

IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's Innovation

Jun 27, 2025

IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025

Jun 23, 2025

IGC Pharma Expands CALMA Trial to Oklahoma, Partnering with Dr. David McCoy at Tekton Research in Yukon

May 22, 2025

IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market

IGC Latest SEC Filings

Jun 27, 2025

[10-K] IGC Pharma, Inc. Files Annual Report

IGC Stock Data

Market Cap 34.82M

Float 76.21M

Insiders Ownership 7.52%

Institutions Ownership 20.91%

Short Percent 1.18%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City POTOMAC